NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Alchemia Ltd (ASX: ACL)

 
ACL Technical Analysis
5
As on 31st Oct 2017 ACL Share Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.01 & Strong Sell for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ACL Share Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 15000 1 Year 0.00 0.00
52 Week High 0.02 | 52 Week Low 0.01
 
ASX Australia Most Active Stocks
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
BPT 1.05 7.14%
PNX 0.01 0.00%
PIO 0.03 0.00%
DJS 3.99 0.00%
KSO 0.40 3900.00%
 
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
 
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
 
 
ACL
Daily Charts
ACL
Intraday Charts
Whats New @
Bazaartrend
ACL
Free Analysis
 
ACL Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
SUPPORT0.00
SUPPORT0.00
 
ACL Target for Month March
4th UP TARGET0.01
3rd UP TARGET0.01
2nd UP TARGET0.01
1st UP TARGET0.01
1st DOWN TARGET0.01
2nd DOWN TARGET0.01
3rd DOWN TARGET0.01
4th DOWN TARGET0.01
 
ACL Weekly Target
4th UP TARGET0.00
3rd UP TARGET0.00
2nd UP TARGET0.00
1st UP TARGET0.00
1st DOWN TARGET0.00
2nd DOWN TARGET0.00
3rd DOWN TARGET0.00
4th DOWN TARGET0.00
 
ACL Target for Year 2021
4th UP TARGET0
3rd UP TARGET0
2nd UP TARGET0
1st UP TARGET0
1st DOWN TARGET0
2nd DOWN TARGET0
3rd DOWN TARGET0
4th DOWN TARGET0
 
 
ACL Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ACL Address
ACL
3 Hi
Eight Mile Plains
Brisbane, QLD 4113
Australia
Phone: 61 7 3340 0200
Fax: 61 7 3340 0222
 
ACL Latest News
 
Your Comments and Response on Alchemia Ltd
 
ACL Business Profile
Alchemia Limited, a biotechnology company, is engaged in the discovery and development of human therapeutic products based on its proprietary drug discovery, drug targeting, and synthesis technologies primarily in Australia. The company’s technologies include HyACT drug delivery technology that enhances the delivery of chemotherapeutic agents to cancer cells; and Versatile Assembly on Stable Templates technology, a small molecule drug discovery technology. It also provides generic fondaparinux, an injectable anticoagulant drug for the prevention and treatment of deep vein thrombosis and pulmonary embolism. In addition, the company develops HA-Irinotecan that is in Phase III clinical trials for the treatment of metastatic colorectal cancer. It has collaboration with Monash Institute of Pharmaceutical Science to discover drug candidates for G-Protein coupled receptors; and University of Queensland to discover novel opioid analgesics with reduced side effects. The company was founded in 1995 and is headquartered in Brisbane, Australia.
 
© 2005-2019 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service